HCW Biologics Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1288587,
    "name": "HCW Biologics Inc.",
    "stock_name": "HCW Biologics Inc.",
    "full_name": "HCW Biologics Inc.",
    "name_url": "stocks-analysis/hcw-biologics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.98",
    "chg": -0.06,
    "chgp": "-2.94%",
    "dir": -1,
    "prev_price": "2.04",
    "mcapval": "8.20",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US40423R1059",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "5.42 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hcw-biologics-inc-1288587-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is HCW Biologics Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-hcw-biologics-inc-technically-bullish-or-bearish-3548963",
        "imagepath": "",
        "date": "2025-09-20 20:29:25",
        "description": "As of 25 August 2025, the technical trend for HCW Biologics Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. However, the daily moving averages are mildly bearish, and both the weekly and monthly Bollinger Bands are bearish, suggesting continued pressure on the price. The KST shows a mixed signal with weekly mildly bullish and monthly bearish readings, and the OBV indicates a bullish stance on the monthly timeframe but no trend on the weekly. \n\nIn terms of performance, HCW Biologics has significantly underperformed the S&P 500 over the past year, with a return of -81.08% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, driven by mixed indicators and significant underperformance relative to the benchmark...."
      },
      {
        "title": "Is HCW Biologics Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-hcw-biologics-inc-overvalued-or-undervalued-3544532",
        "imagepath": "",
        "date": "2025-09-20 18:48:46",
        "description": "As of 14 August 2025, the valuation grade for HCW Biologics Inc. moved from risky to does not qualify, indicating a significant deterioration in its financial standing. The company is overvalued given its negative valuation ratios, including a Price to Book Value of -1.70, an EV to EBIT of -2.12, and an EV to EBITDA of -2.38. These metrics suggest that the company's financial performance is not only poor but also unsustainable compared to its peers.\n\nIn comparison to its industry, HCW Biologics Inc. shows a stark contrast with peers like Elicio Therapeutics, Inc., which has an EV to EBITDA of -4.1277, and Eliem Therapeutics, Inc., with an EV to EBITDA of -1.5652. The company's returns have been dismal, with a year-to-date decline of -74.56% compared to a positive return of 12.22% for the S&P 500, further reinforcing the notion that HCW Biologics is not a viable investment at this time...."
      }
    ],
    "total": 6,
    "sid": "1288587",
    "stock_news_url": "https://www.marketsmojo.com/news/hcw-biologics-inc-1288587"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is HCW Biologics Inc. technically bullish or bearish?

2025-09-20 20:29:25

As of 25 August 2025, the technical trend for HCW Biologics Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. However, the daily moving averages are mildly bearish, and both the weekly and monthly Bollinger Bands are bearish, suggesting continued pressure on the price. The KST shows a mixed signal with weekly mildly bullish and monthly bearish readings, and the OBV indicates a bullish stance on the monthly timeframe but no trend on the weekly. In terms of performance, HCW Biologics has significantly underperformed the S&P 500 over the past year, with a return of -81.08% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, driven by mixed indicators and significant underperformance relative to the benchmark....

Is HCW Biologics Inc. overvalued or undervalued?

2025-09-20 18:48:46

As of 14 August 2025, the valuation grade for HCW Biologics Inc. moved from risky to does not qualify, indicating a significant deterioration in its financial standing. The company is overvalued given its negative valuation ratios, including a Price to Book Value of -1.70, an EV to EBIT of -2.12, and an EV to EBITDA of -2.38. These metrics suggest that the company's financial performance is not only poor but also unsustainable compared to its peers. In comparison to its industry, HCW Biologics Inc. shows a stark contrast with peers like Elicio Therapeutics, Inc., which has an EV to EBITDA of -4.1277, and Eliem Therapeutics, Inc., with an EV to EBITDA of -1.5652. The company's returns have been dismal, with a year-to-date decline of -74.56% compared to a positive return of 12.22% for the S&P 500, further reinforcing the notion that HCW Biologics is not a viable investment at this time....

View All News